Dev Prasad

Stock Analyst at LUCID CAPITAL MARKETS

(n/a)

# 4,726

Out of 4,854 analysts

3

Total ratings

n/a

Success rate

-52.35%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Dev Prasad

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AVTX Avalo Therapeutics	Initiates: Buy	$24	$4.10	+485.37%	1	Dec 17, 2024
	IBIO iBio, Inc.	Initiates: Buy	$6	$0.98	+509.26%	1	Dec 17, 2024
	CALC CalciMedica	Initiates: Buy	$13	$1.76	+638.64%	1	Dec 17, 2024

Avalo Therapeutics

Dec 17, 2024

Initiates: Buy

Price Target: $24

Current: $4.10

Upside: +485.37%

iBio, Inc.

Dec 17, 2024

Initiates: Buy

Price Target: $6

Current: $0.98

Upside: +509.26%

CalciMedica

Dec 17, 2024

Initiates: Buy

Price Target: $13

Current: $1.76

Upside: +638.64%